Published in Biochem J on June 15, 1993
Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun (1995) 2.50
A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol (2003) 2.28
Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells. PLoS One (2013) 1.54
Sphingolipids as Mediators in the Crosstalk between Microbiota and Intestinal Cells: Implications for Inflammatory Bowel Disease. Mediators Inflamm (2016) 1.39
Dimyristoylphosphatidylcholine/C16:0-ceramide binary liposomes studied by differential scanning calorimetry and wide- and small-angle x-ray scattering. Biophys J (2000) 1.23
Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem J (1998) 1.17
Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor. EMBO J (1997) 1.09
Tyrosine phosphorylation and activation of a new mitogen-activated protein (MAP)-kinase cascade in human neutrophils stimulated with various agonists. Biochem J (1996) 1.09
Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol (2004) 1.09
Effect of lipopolysaccharide on mitogen-activated protein kinases and cytosolic phospholipase A2. Biochem J (1995) 1.07
Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice. J Clin Invest (1999) 1.06
Platelet-activating factor-induced NF-kappaB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflamm Bowel Dis (2010) 1.03
Platelet-activating factor: the biosynthetic and catabolic enzymes. Biochem J (1995) 1.02
Role of platelet-activating factor in the pathogenesis of acute pancreatitis. World J Gastroenterol (2006) 1.02
Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis. Gut (2004) 1.02
Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. Br J Pharmacol (2005) 1.02
Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. Infect Immun (1999) 0.98
Group A Streptococcus secreted esterase hydrolyzes platelet-activating factor to impede neutrophil recruitment and facilitate innate immune evasion. PLoS Pathog (2012) 0.98
Intestinal alkaline sphingomyelinase hydrolyses and inactivates platelet-activating factor by a phospholipase C activity. Biochem J (2006) 0.95
Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. Biochem J (1997) 0.94
Traumatic brain injury-associated coagulopathy. J Neurotrauma (2012) 0.93
Bioactive lipids in Trypanosoma cruzi infection. Adv Parasitol (2011) 0.93
Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia. Leuk Lymphoma (2012) 0.92
Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology (2000) 0.92
Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study. Lipids Health Dis (2010) 0.92
Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. Am J Pathol (1999) 0.91
A murine platelet-activating factor receptor gene: cloning, chromosomal localization and up-regulation of expression by lipopolysaccharide in peritoneal resident macrophages. Biochem J (1996) 0.89
Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. J Exp Med (2005) 0.89
Fluid shear stress increases neutrophil activation via platelet-activating factor. Biophys J (2014) 0.87
Impaired leukocyte influx in cervix of postterm women not responding to prostaglandin priming. Reprod Biol Endocrinol (2008) 0.87
Serum activity of platelet-activating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage. PLoS One (2009) 0.87
Significance of platelet activating factor receptor expression in pancreatic tissues of rats with severe acute pancreatitis and effects of BN52021. World J Gastroenterol (2007) 0.86
Effects of glycosaminoglycans and glycosphingolipids on cytosolic phospholipases A2 from bovine brain. Biochem J (1994) 0.85
Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression. Br J Pharmacol (2005) 0.85
Platelet-activating factor increases pH(i) in bovine neutrophils through the PI3K-ERK1/2 pathway. Br J Pharmacol (2003) 0.85
Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. Thorax (1997) 0.85
Characterization of streptococcal platelet-activating factor acetylhydrolase variants that are involved in innate immune evasion. Infect Immun (2013) 0.84
Protein expression profiling during chick retinal maturation: a proteomics-based approach. Proteome Sci (2008) 0.84
IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). Clin Exp Immunol (2000) 0.84
Decrease of plasma platelet-activating factor acetylhydrolase activity in lipopolysaccharide induced mongolian gerbil sepsis model. PLoS One (2010) 0.84
Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. Immunology (1997) 0.83
Platelet-activating factor increases mucosal permeability in rat intestine via tyrosine phosphorylation of E-cadherin. Br J Pharmacol (2000) 0.83
PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons. Front Cell Neurosci (2010) 0.82
Interaction of tumor cells with vascular endothelia: role of platelet-activating factor. Clin Exp Metastasis (2000) 0.81
Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages. Biochem J (2001) 0.81
Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine: regulation by dexamethasone and gut flora. Immunology (1999) 0.81
Independent regulation of periarteriolar and perivenular nitric oxide mechanisms in the in vivo hamster cheek pouch microvasculature. Microcirculation (2009) 0.80
IL-1 beta and IL-6 stimulate the production of platelet-activating factor (PAF) by cultured rabbit synovial cells. Clin Exp Immunol (1995) 0.79
The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. Clin Exp Immunol (2001) 0.79
Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art. Exp Biol Med (Maywood) (2015) 0.79
Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis. Dig Dis Sci (2009) 0.79
Effect of increased hepatic platelet activating factor and its receptor portal hypertension in CCl4-induced liver cirrhosis. World J Gastroenterol (2006) 0.79
A measure of the broad substrate specificity of enzymes based on 'duplicate' catalytic residues. PLoS One (2012) 0.79
Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi. PLoS Negl Trop Dis (2014) 0.78
Nupafant, a PAF-antagonist prototype for suppression of ventricular fibrillation without liability for QT prolongation? Br J Pharmacol (2006) 0.78
Platelet-activating factor in liver injury: a relational scope. World J Gastroenterol (2006) 0.78
Expression of human platelet-activating factor receptor gene in EoL-1 cells following butyrate-induced differentiation. Biochem J (1995) 0.78
Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw. Br J Pharmacol (2003) 0.78
Characterization of platelet-activating factor binding to human airway epithelial cells: modulation by fatty acids and ion-channel blockers. Biochem J (1994) 0.78
Human neutrophils specifically interact with human monocyte-derived macrophage monolayers. Inflammation (2000) 0.78
Prolonged activation of phospholipase D in Chinese hamster ovary cells expressing platelet-activating-factor receptor lacking cytoplasmic C-terminal tail. Biochem J (1997) 0.77
PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer. Int J Clin Exp Pathol (2015) 0.77
Role of platelet-activating factor in Chinese hamster ovary cell responses to cholera toxin. J Clin Invest (1997) 0.77
The intestinal anti-inflammatory effect of dersalazine sodium is related to a down-regulation in IL-17 production in experimental models of rodent colitis. Br J Pharmacol (2012) 0.76
LIS1 Regulates Osteoclastogenesis through Modulation of M-SCF and RANKL Signaling Pathways and CDC42. Int J Biol Sci (2016) 0.75
Na+/H+ exchange in hypertension and in diabetes mellitus--facts and hypotheses. Basic Res Cardiol (1996) 0.75
Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis. World J Gastroenterol (2008) 0.75
Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro study. Drug Des Devel Ther (2016) 0.75
Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model. Clin Exp Immunol (1998) 0.75
Platelet Activating Factor Receptor Activation Improves siRNA Uptake and RNAi Responses in Well-differentiated Airway Epithelia. Mol Ther Nucleic Acids (2014) 0.75
Nuclear localization of platelet-activating factor receptor controls retinal neovascularization. Cell Discov (2016) 0.75
Hepatic stellate cells may be potential effectors of platelet activating factor induced portal hypertension. World J Gastroenterol (2008) 0.75
Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases. Mol Neurobiol (2016) 0.75
Inhibition of prostaglandin G/H synthase unveils a potent effect of platelet activating factor on the permeability of bovine aortic endothelial cells to albumin. Inflammation (2002) 0.75
The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (1984) 28.58
Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature (1984) 25.71
Studies and perspectives of protein kinase C. Science (1986) 14.73
Inositol trisphosphate and diacylglycerol as second messengers. Biochem J (1984) 14.37
Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med (1972) 5.38
Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem (1979) 4.31
Leukotrienes are potent constrictors of human bronchi. Nature (1980) 4.04
Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. Nature (1987) 3.39
Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol (1991) 3.05
[Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine]. C R Seances Acad Sci D (1979) 2.53
The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41
Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol (1979) 2.31
Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung. Nature (1991) 2.28
Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A (1984) 2.28
Release of vasoactive amines from rabbit platelets induced by sensitized mononuclear leukocytes and antigen. J Exp Med (1970) 2.22
Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci U S A (1986) 2.18
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest (1985) 2.16
Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers. Trends Neurosci (1988) 2.14
Platelet-activating factor. J Biol Chem (1990) 2.13
L-myo-inositol 1,4,5,6-tetrakisphosphate is present in both mammalian and avian cells. Biochem J (1988) 2.10
Structural analysis of purified platelet-activating factor by lipases. Nature (1977) 2.09
Platelet-activating factor, a new mediator of anaphylaxis and immune complex deposition from rabbit and human basophils. Nature (1974) 1.97
Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med (1987) 1.95
Antihypertensive activity of an alkyl ether analog of phosphatidylcholine. Biochem Biophys Res Commun (1979) 1.94
Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem (1986) 1.87
Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J Biol Chem (1980) 1.61
Nonimmunological production of leukotrienes induced by platelet-activating factor. Science (1982) 1.58
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest (1986) 1.57
Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J Biol Chem (1988) 1.52
Specific receptor sites for 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranes. Biochemistry (1983) 1.49
Destruction of rabbit platelets in the allergic response of sensitized leukocytes. I. Demonstration of a fluid phase intermediate. J Immunol (1971) 1.48
Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. J Biol Chem (1988) 1.44
Acetyl glyceryl ether phosphorylcholine stimulates leukotriene B4 synthesis in human polymorphonuclear leukocytes. J Clin Invest (1982) 1.43
Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem (1991) 1.39
Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. J Biol Chem (1982) 1.39
The human leukocyte platelet-activating factor receptor. cDNA cloning, cell surface expression, and construction of a novel epitope-bearing analog. J Biol Chem (1992) 1.34
Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. J Immunol (1984) 1.34
Specific binding of phospholipid platelet-activating factor by human platelets. J Immunol (1982) 1.33
Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. Med Res Rev (1985) 1.32
Bacterial lipopolysaccharide priming of P388D1 macrophage-like cells for enhanced arachidonic acid metabolism. Platelet-activating factor receptor activation and regulation of phospholipase A2. J Biol Chem (1990) 1.30
Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol (1990) 1.29
Activation of 1-alkyl-2-lysoglycero-3-phosphocholine. Acetyl-CoA transferase during phagocytosis in human polymorphonuclear leukocytes. J Biol Chem (1982) 1.29
Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils. J Biol Chem (1983) 1.26
Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms. J Lipid Mediat (1992) 1.26
Platelet-activating factor stimulates metabolism of phosphoinositides in horse platelets: possible relationship to Ca2+ mobilization during stimulation. Proc Natl Acad Sci U S A (1983) 1.25
Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. Immunology (1983) 1.24
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. J Biol Chem (1984) 1.21
Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells. J Biol Chem (1988) 1.21
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. J Biol Chem (1983) 1.21
Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. Biochem J (1986) 1.21
Coronary vasoconstriction in the rat, isolated perfused heart induced by platelet-activating factor is mediated by leukotriene C4. Br J Pharmacol (1986) 1.20
Human airway monohydroxyeicosatetraenoic acid generation and mucus release. J Clin Invest (1983) 1.20
Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun (1991) 1.19
The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C. J Biol Chem (1989) 1.16
Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. J Biol Chem (1987) 1.16
Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. J Biol Chem (1986) 1.16
What's in a Name? The American Society for Investigative Pathology. Am J Pathol (1993) 1.15
Platelet-activating factor induces tyrosine phosphorylation in human neutrophils. J Biol Chem (1991) 1.14
Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. J Biol Chem (1990) 1.10
Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. J Biol Chem (1988) 1.08
AGEPC (platelet activating factor) induced stimulation of rabbit platelets: effects on phosphatidylinositol, di- and triphosphoinositides and phosphatidic acid metabolism. Biochem Biophys Res Commun (1982) 1.08
Characteristics of the binding of platelet-activating factor to platelets of different animal species. Eur J Pharmacol (1984) 1.07
Binding and metabolism of platelet-activating factor by human neutrophils. J Clin Invest (1986) 1.06
Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. J Biol Chem (1984) 1.05
Platelet-activating factor stimulates the phosphatidylinositol cycle. Appearance of phosphatidic acid is associated with the release of serotonin in horse platelets. J Biol Chem (1982) 1.05
Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver. Biochem Biophys Res Commun (1984) 1.05
Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages. Biochim Biophys Acta (1984) 1.04
Endotoxin stimulates glycogenolysis in the liver by means of intercellular communication. J Biol Chem (1988) 1.04
Biosynthesis of platelet-activating factor. VI. Precursor of platelet-activating factor and acetyltransferase activity in isolated rat kidney cells. Lab Invest (1984) 1.04
The effect of acetylglyceryl ether phosphorylcholine on glycogenolysis and phosphatidylinositol 4,5-bisphosphate metabolism in rat hepatocytes. J Biol Chem (1984) 1.04
Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells. J Clin Invest (1984) 1.03
Specific binding sites for platelet activating factor in human lung tissues. Biochem Biophys Res Commun (1985) 1.01
Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore. Biochem Biophys Res Commun (1982) 1.01
Arachidonic acid release in rabbit neutrophils. Biochem J (1989) 1.00
Identification of platelet-activating factor receptors in P388D1 murine macrophages. J Immunol (1988) 0.99
Role of prostaglandin synthesis in rabbit platelet activation induced by basophil-derived platelet-activating factor. J Immunol (1978) 0.99
Involvement of pp60c-src in platelet-activating factor-stimulated platelets. Evidence for translocation from cytosol to membrane. J Biol Chem (1991) 0.99
Stimulation of arachidonic acid release by guanine nucleotide in saponin-permeabilized neutrophils: evidence for involvement of GTP-binding protein in phospholipase A2 activation. Arch Biochem Biophys (1988) 0.97
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets. FEBS Lett (1983) 0.97
Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils. J Immunol (1987) 0.96
G-protein subunits. Who carries what message? Nature (1989) 0.96
Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2. J Biol Chem (1985) 0.96
Occupancy of platelet receptors for platelet-activating factor in patients with septicemia. J Clin Invest (1989) 0.96
1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelets. Biochem Biophys Res Commun (1981) 0.96
Ionic and GTP regulation of binding of platelet-activating factor to receptors and platelet-activating factor-induced activation of GTPase in rabbit platelet membranes. J Biol Chem (1986) 0.94
Stimulation of glycogenolysis and platelet-activating factor production by heat-aggregated immunoglobulin G in the perfused rat liver. J Biol Chem (1984) 0.94
Bidirectional effects of protein kinase C activators. Studies with human neutrophils and platelet-activating factor. J Biol Chem (1989) 0.94
Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine. Mol Pharmacol (1990) 0.94
Platelet-activating factor induces an increase in intracellular calcium and expression of regulatory genes in human B lymphoblastoid cells. J Immunol (1991) 0.94
Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187. Biochim Biophys Acta (1983) 0.92
1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine: a novel source of arachidonic acid in neutrophils stimulated by the calcium ionophore A23187. Biochem Biophys Res Commun (1983) 0.92
Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J (1984) 0.92
Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways. J Biol Chem (1992) 0.91
Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor). J Biol Chem (1982) 0.91
Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages. J Immunol (1982) 0.91
PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. Am J Physiol (1988) 0.91
Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation (1991) 0.90
Asymmetrical crossing barriers in angiosperms. Proc Biol Sci (2001) 2.37
A survey of physicians' attitudes and practices related to exercise promotion. Prev Med (1992) 1.61
Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest (1975) 1.59
Bone morphogenetic protein-9. An autocrine/paracrine cytokine in the liver. J Biol Chem (2000) 1.48
Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer. Oncol Nurs Forum (1997) 1.32
Antibody-independent activation of human C1 after interaction with heart subcellular membranes. J Immunol (1973) 1.29
The regulation of pyruvate dehydrogenase in the isolated perfused rat heart. J Biol Chem (1978) 1.28
Complement localization and mediation of ischemic injury in baboon myocardium. J Clin Invest (1980) 1.24
In vitro activation of complement by isolated human heart subcellular membranes. J Immunol (1979) 1.24
Studies of the effects of beta-adrenergic agonists on the regulation of pyruvate dehydrogenase in the perfused rat heart. J Biol Chem (1980) 1.22
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. J Biol Chem (1984) 1.21
Acetylglyceryl ether phosphorylcholine. A potent activator of hepatic phosphoinositide metabolism and glycogenolysis. J Biol Chem (1983) 1.21
Platelet-activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. J Biol Chem (1986) 1.16
Endothelin, a potent peptide agonist in the liver. J Biol Chem (1990) 1.14
End-of-life decision making by adolescents, parents, and healthcare providers in pediatric oncology: research to evidence-based practice guidelines. Cancer Nurs (2001) 1.12
Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am J Physiol (1999) 1.11
Development of complement-fixing 19S, anti-heart mitochondria autoantibody, following myocardial infarction in dogs. Circ Res (1971) 1.10
The analysis of acyl-coenzyme A derivatives by reverse-phase high-performance liquid chromatography. Anal Biochem (1983) 1.10
The effect of fatty acids on the regulation of pyruvate dehydrogenase in perfused rat liver. Eur J Biochem (1978) 1.08
Role of pyruvate transporter in the regulation of the pyruvate dehydrogenase multienzyme complex in perfused rat liver. Biochemistry (1982) 1.06
Regulation of the pyruvate dehydrogenase multienzyme complex. Annu Rev Nutr (1993) 1.05
Studies on the regulation of pyruvate dehydrogenase in the isolated perfused rat heart. J Biol Chem (1979) 1.04
Studies on the relationship between ketogenesis and pyruvate oxidation in isolated rat liver mitochondria. J Biol Chem (1978) 1.04
Regulation of pyruvate dehydrogenase by fatty acid in isolated rat liver mitochondria. J Biol Chem (1976) 1.04
Expression of nitric-oxide synthase in rat Kupffer cells is regulated by cAMP. J Biol Chem (1998) 1.04
The effect of acetylglyceryl ether phosphorylcholine on glycogenolysis and phosphatidylinositol 4,5-bisphosphate metabolism in rat hepatocytes. J Biol Chem (1984) 1.04
Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology (1997) 1.04
Studies on the activation and inactivation of the branched chain alpha-keto acid dehydrogenase in the perfused rat heart. J Biol Chem (1980) 1.03
Regulation of pyruvate dehydrogenase complex in ischemic rat heart. Am J Physiol (1984) 1.03
Evidence for the regulation of the branched chain alpha-keto acid dehydrogenase multienzyme complex by a phosphorylation/dephosphorylation mechanism. Biochemistry (1982) 1.02
A quantitative genetic analysis of nuclear-cytoplasmic male sterility in structured populations of Silene vulgaris. Genetics (2001) 1.02
Stimulation of glycogenolysis by adenine nucleotides in the perfused rat liver. Biochem J (1986) 1.01
Regulation of the branched chain alpha-keto acid and pyruvate dehydrogenases in the perfused rat heart. J Biol Chem (1982) 0.99
Cardiovascular and metabolic costs of forward, backward, and lateral motion. Med Sci Sports Exerc (1998) 0.99
Role of platelet-activating factor in pancreatitis-associated acute lung injury in the rat. Am J Pathol (1992) 0.98
The regulation of the pyruvate dehydrogenase complex in the perfused rat liver: a role for the mitochondrial monocarboxylate translocator. Arch Biochem Biophys (1982) 0.98
Platelet-activating factor: a mediator of pancreatic inflammation during cerulein hyperstimulation. Am J Pathol (1993) 0.97
Stimulation of glycogenolysis and vasoconstriction by adenosine and adenosine analogues in the perfused rat liver. Biochem J (1987) 0.97
Osteogenic protein-1-mediated insulin-like growth factor gene expression in primary cultures of rat osteoblastic cells. Endocrinology (1996) 0.96
The effects of alpha-adrenergic agonists on the regulation of the branched chain alpha-ketoacid oxidation in the perfused rat liver. J Biol Chem (1982) 0.95
Control of citrate formation in rat liver mitochondria. Biochem Biophys Res Commun (1967) 0.95
A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. Biochem J (1992) 0.95
Glycogenolytic and haemodynamic responses to heat-aggregated immunoglobulin G and prostaglandin E2 in the perfused rat liver. Biochem J (1987) 0.94
Stimulation of glycogenolysis and platelet-activating factor production by heat-aggregated immunoglobulin G in the perfused rat liver. J Biol Chem (1984) 0.94
Regulation of the glycine cleavage system in isolated rat liver mitochondria. J Biol Chem (1983) 0.94
Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatology (1995) 0.93
Stimulation of glycogenolysis and vasoconstriction in the perfused rat liver by the thromboxane A2 analogue U-46619. J Biol Chem (1987) 0.93
Two distinct pathways of platelet-activating factor-induced hydrolysis of phosphoinositides in primary cultures of rat Kupffer cells. J Biol Chem (1990) 0.92
Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem (1997) 0.91
Platelet-activating factor-stimulated protein tyrosine phosphorylation and eicosanoid synthesis in rat Kupffer cells. Evidence for calcium-dependent and protein kinase C-dependent and -independent pathways. J Biol Chem (1992) 0.91
Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. Am J Pathol (1999) 0.91
Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology (1992) 0.90
The inactivation of pyruvate dehydrogenase by fatty acid in isolated rat liver mitochondria. Biochem Biophys Res Commun (1975) 0.90
Occurrence of an endogenous inhibitor of platelet-activating factor in rat liver. J Biol Chem (1987) 0.90
Role of platelet-activating factor in hepatic responses after bile duct ligation in rats. Am J Physiol (1992) 0.90
The regulation of pyruvate dehydrogenase in isolated beef heart mitochondria. The role of calcium, magnesium, and permeant anions. J Biol Chem (1974) 0.89
Characterization of the binding of purified human C1q to heart mitochondrial membranes. J Biol Chem (1981) 0.89
Production and effects of platelet-activating factor in the rat brain. Biochim Biophys Acta (1988) 0.89
The regulation of pyruvate oxidation during membrane depolarization of rat brain synaptosomes. Biochem J (1980) 0.89
Studies of mitochondrial calcium movements using chlorotetracycline. Biochim Biophys Acta (1976) 0.89
Regulation of platelet-activating factor receptors in rat Kupffer cells. J Biol Chem (1989) 0.88
Relationship between fire fighting suppression tasks and physical fitness. Ergonomics (1999) 0.88
The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. J Biol Chem (2000) 0.88
Studies on the regulation of pyruvate dehydrogenase in isolated beef heart mitochondria. Arch Biochem Biophys (1975) 0.87
Regulation of the glycine cleavage system in the isolated perfused rat liver. J Biol Chem (1984) 0.87
C1q binding and C1 activation by various isolated cellular membranes. J Immunol (1983) 0.87
alpha-Ketobutyrate metabolism in perfused rat liver: regulation of alpha-ketobutyrate decarboxylation and effects of alpha-ketobutyrate on pyruvate dehydrogenase. Arch Biochem Biophys (1985) 0.86
Characterization of anti-heart mitochondria autoantibodies produced in dogs following myocardial infarction. Circ Res (1974) 0.86
Regulation of platelet-activating factor receptor and PAF receptor-mediated arachidonic acid release by protein kinase C activation in rat Kupffer cells. Arch Biochem Biophys (1990) 0.86
Platelet-activating factor-stimulated hepatic glycogenolysis is not mediated through cyclooxygenase-derived metabolites of arachidonic acid. J Biol Chem (1989) 0.86
Studies of the energy-dependent uptake of divalent metal ions by beef heart mitochondria. J Biol Chem (1974) 0.86
Associations among cytoplasmic molecular markers, gender, and components of fitness in Silene vulgaris, a gynodioecious plant. Mol Ecol (2003) 0.86
Autoantigenic specificities of liver mitochondrial membranes. Clin Exp Immunol (1972) 0.86
Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat. Am J Pathol (1990) 0.85
Studies on the regulation of the branched chain alpha-keto acid dehydrogenase in the perfused rat liver. J Biol Chem (1981) 0.85
Platelet-activating factor-mediated synthesis of prostaglandins in rat Kupffer cells. Biochim Biophys Acta (1992) 0.85
Platelet-activating factor as an intercellular signal in neutrophil-dependent platelet activation. J Immunol (1992) 0.84
Potassium-mediated stimulation of hepatic glycogenolysis. J Biol Chem (1987) 0.84
Effects of beta-adrenergic stimulation on 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine-mediated vasoconstriction and glycogenolysis in the perfused rat liver. J Biol Chem (1986) 0.84
Studies on the regulation of the branched chain alpha-keto acid dehydrogenase in the perfused rat heart. J Biol Chem (1979) 0.84
Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes. Biochem J (1992) 0.84
Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. Biochem Pharmacol (1986) 0.84
Effects of alpha-ketoisovalerate on bovine heart pyruvate dehydrogenase complex and pyruvate dehydrogenase kinase. J Biol Chem (1986) 0.84
Biosynthesis of platelet-activating factor by cultured rat Kupffer cells stimulated with calcium ionophore A23187. Biochem J (1989) 0.84
The stimulation of hepatic gluconeogenesis by acetoacetate precursors. A role for the monocarboxylate translocator. J Biol Chem (1984) 0.84
Secretory PAF-acetylhydrolase of the rat hepatobiliary system: characterization and partial purification. Am J Physiol (1998) 0.83
Chlorotetracycline-associated fluorescence changes during calcium uptake and release by rat brain synaptosomes. J Neurochem (1976) 0.83
Effects of calcium channel antagonists on LPS-induced hepatic iNOS expression. Am J Physiol (1999) 0.83
The effects of chlorotetracycline on calcium movements in isolated rat liver mitochondria. Arch Biochem Biophys (1978) 0.83
Changes in endogenous substrates of isolated rabbit heart mitochondria during storage. J Biol Chem (1967) 0.83
Pyruvate dehydrogenase multienzyme complex. Characterization of assembly intermediates by sedimentation velocity analysis. J Biol Chem (1994) 0.83
Voice problems and risk factors among aerobics instructors. J Voice (1998) 0.82
Regulation of endothelin synthesis in hepatic endothelial cells. Am J Physiol (1998) 0.82
Suppression of lipopolysaccharide-induced nitric oxide synthase expression by platelet-activating factor receptor antagonists in the rat liver and cultured rat Kupffer cells. Hepatology (1999) 0.82
Control of metabolism in brown adipose tissue. Lipids (1970) 0.82
Regulation of platelet-activating factor receptor and platelet-activating factor receptor-mediated biological responses by cAMP in rat Kupffer cells. J Biol Chem (1990) 0.82
The effect of the monocarboxylate translocator inhibitor, alpha-cyanocinnamate, on the oxidation of branched chain alpha-keto acids in rat liver. Arch Biochem Biophys (1980) 0.82